Indian Journal of Clinical and Experimental Ophthalmology

Print ISSN: 2395-1443

Online ISSN: 2395-1451

CODEN : IJCEKF

Indian Journal of Clinical and Experimental Ophthalmology (IJCEO) is open access, a peer-reviewed medical journal, published quarterly, online, and in print, by the Innovative Education and Scientific Research Foundation (IESRF) since 2015. To fulfil our aim of rapid dissemination of knowledge, we publish articles ‘Ahead of Print’ on acceptance. In addition, the journal allows free access (Open Access) to its content, which is likely to attract more readers and citations of articles published in IJCEO. Manuscripts must be prepared in more...

Article type

Original Article


Article page

69-72


Authors Details

Rahul Prasad*, Antabha Bandyopadhyay, Deepti Tiwari, Bibha Singh


Article Metrics


View Article As

 


Downlaod Files

   






Article statistics

Viewed: 774

PDF Downloaded: 540


Nepafenac vs bromfenac: A comparative study to determine their role in maintaining mydriasis during cataract surgery


Original Article

Author Details : Rahul Prasad*, Antabha Bandyopadhyay, Deepti Tiwari, Bibha Singh

Volume : 7, Issue : 1, Year : 2021

Article Page : 69-72

https://doi.org/10.18231/j.ijceo.2021.014



Suggest article by email

Get Permission

Abstract

Aim: To assess and compare the role of topical nepafenac (0.1%) v/s bromfenac (0.09%) in sustaining intra-operative mydriasis while doing cataract extraction.
Study Design: Prospective, randomized study.
Place and Duration of Study: Regional Institute of Ophthalmology, Rajendra Institute of Medical Sciences (RIMS), Ranchi (Jharkhand). The duration of study was from June 2019 to February 2020.
Materials and Methods: Topical NSAIDs (nepafenac and bromfenac) and carboxymethylcellulose (control) were administered to the cataract patients before Phaco surgery. Pupillary diameters were assessed first at starting of surgery and then after completing the surgery; average values were calculated for the three groups. Study was done on 90 patients having age 40-80 years, planned for cataract surgery with PCIOL
implantation.
Results: in group A (i.e. control) reduction in pupillary diameter came out to be more statistically significant unlike in group B (nepafenac) and in group C (bromfenac) (p <0> Conclusion: Both nepafenac (0.1%) and bromfenac (0.09%) administered a day before operation are helpful in sustaining pupil size intra-operatively but bromfenac comparatively seemed to be better than nepafenac in sustaining mydriasis during SICS/Phaco.

Keywords: Bromfenac, Cataract, Mydriasis, Nepafenac.


How to cite : Prasad R , Bandyopadhyay A , Tiwari D , Singh B , Nepafenac vs bromfenac: A comparative study to determine their role in maintaining mydriasis during cataract surgery. Indian J Clin Exp Ophthalmol 2021;7(1):69-72

This is an Open Access (OA) journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.